ES541780A0 - Tetrahidrotienopiridinas - Google Patents

Tetrahidrotienopiridinas

Info

Publication number
ES541780A0
ES541780A0 ES541780A ES541780A ES541780A0 ES 541780 A0 ES541780 A0 ES 541780A0 ES 541780 A ES541780 A ES 541780A ES 541780 A ES541780 A ES 541780A ES 541780 A0 ES541780 A0 ES 541780A0
Authority
ES
Spain
Prior art keywords
organic radical
tetrahidrotienopiridinas
tetrahydrothienopyridines
hypotensive
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541780A
Other languages
English (en)
Other versions
ES8607314A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8607314A1 publication Critical patent/ES8607314A1/es
Publication of ES541780A0 publication Critical patent/ES541780A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES541780A 1984-04-06 1985-03-29 Tetrahidrotienopiridinas Expired ES8607314A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843412947 DE3412947A1 (de) 1984-04-06 1984-04-06 Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8607314A1 ES8607314A1 (es) 1986-06-01
ES541780A0 true ES541780A0 (es) 1986-06-01

Family

ID=6232826

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541780A Expired ES8607314A1 (es) 1984-04-06 1985-03-29 Tetrahidrotienopiridinas

Country Status (13)

Country Link
US (1) US4642310A (es)
EP (1) EP0157324B1 (es)
JP (1) JPH0633276B2 (es)
KR (1) KR850007600A (es)
AT (1) ATE36854T1 (es)
AU (1) AU569787B2 (es)
CA (1) CA1255660A (es)
DE (2) DE3412947A1 (es)
DK (1) DK163831B (es)
ES (1) ES8607314A1 (es)
HU (1) HU191784B (es)
IL (1) IL74800A (es)
ZA (1) ZA852561B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311005A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
DE4313690A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
WO1998040385A1 (en) * 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
KR20200130626A (ko) 2019-05-11 2020-11-19 류승문 정현직교 파형과 바이너리 cdma의 융합에 의해 직교도를 높인 변조신호 생성 방법
KR20190060731A (ko) 2019-05-14 2019-06-03 류승문 정현직교 파형과 바이너리 cdma의 융합에 의해 직교도를 높인 변조신호를 소프트웨어로 구현하는 방법
KR20190062338A (ko) 2019-05-17 2019-06-05 류승문 직교정현 파형과 바이너리 cdma가 융합된 음파 변복조 기술

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948923A (en) * 1972-03-06 1976-04-06 Bayer Aktiengesellschaft Pentahydroqunolizine derivatives
US3935220A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft Tetrahydroimidazolo[1,2-a]pyridine derivatives
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
EP0111455A3 (de) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Ungesättigte Lactone
EP0111453A1 (de) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Amid-Verbindungen

Also Published As

Publication number Publication date
KR850007600A (ko) 1985-12-07
ATE36854T1 (de) 1988-09-15
DK154385A (da) 1985-10-07
AU569787B2 (en) 1988-02-18
EP0157324A3 (en) 1987-06-16
JPH0633276B2 (ja) 1994-05-02
AU4083485A (en) 1985-10-10
DK163831B (da) 1992-04-06
DE3412947A1 (de) 1985-10-17
HUT37797A (en) 1986-02-28
ES8607314A1 (es) 1986-06-01
US4642310A (en) 1987-02-10
CA1255660A (en) 1989-06-13
DK154385D0 (da) 1985-04-03
IL74800A0 (en) 1985-07-31
ZA852561B (en) 1985-11-27
JPS60228485A (ja) 1985-11-13
EP0157324A2 (de) 1985-10-09
IL74800A (en) 1989-08-15
EP0157324B1 (de) 1988-08-31
HU191784B (en) 1987-04-28
DE3564684D1 (en) 1988-10-06

Similar Documents

Publication Publication Date Title
ES520300A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
ES8800250A1 (es) Procedimiento para preparar acidos propano-fosfonosos susti-tuidos
FI911330A (fi) 1,4,7,10-tetra-azacyklododekan -butyltrioler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
SE8404019D0 (sv) Oftalmiskt medel
FI852806A0 (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
ES541780A0 (es) Tetrahidrotienopiridinas
DK264687D0 (da) Substituerede 6-hydroxymethyl-carbapenem-antibiotika, deres fremstilling og anvendelse
FI871637A (fi) Foerfarande foer framstaellning av 1,5-benzotiazepinderivat.
DE3561153D1 (de) Benzoylurea derivatives
ATE74138T1 (de) Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten.
FI843155A (fi) Framstaellning av indolinderivat och deras terapeutiska tillaempning.
DK588484A (da) Thiolan-2,4-dion-3-carboxamider, deres fremstilling og anvendelse tilbekaempelse af skadelige organismer
FI870067A0 (fi) Metionin-substituerade 1,4-dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning.
DK178384D0 (da) Iminosulfonamider samt deres fremstilling og anvendelse
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
GB2018766A (en) 6-Sulphamyl benzimidazoles and benzimidazolidines
ES2054631T3 (es) 1-(2-halogeno-alcoxi-bencenosulfonil)-3-heteroaril-ureas, 3-substituidas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203